peptideNot FDA-approvedResearch chemicalProhibited in sport (WADA S2)Raises ACTH and cortisol as well as GH
GHRP-6Benefits, Dosage & Interactions
GHRP-6, or Growth Hormone-Releasing Hexapeptide, is a synthetic peptide known for its ability to stimulate the release of growth hormone (GH) from the pituitary gland. It belongs to a class of compounds called growth hormone secretagogues. Research on GHRP-6 focuses on weight loss, tissue recovery, and muscle and strength.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence
One published human randomized trial; results not yet replicated.
Plasma half-life
~0.9 h
Typical timing
bedtime
Default unit
mcg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
Worked example: a 5 mg vial reconstituted with 2 ml of bacteriostatic water gives 2.5 mg/ml, so a 100 mcg amount measures 4 units on a U-100 syringe. Open this in the reconstitution calculator.
Reported for GHRP-6 in the cited sources. Published ranges are not dosing advice.
GHRP-6 compared with similar compounds
| Attribute | GHRP-2 | GHRP-6 | Hexarelin | Ipamorelin |
|---|---|---|---|---|
| Class | Ghrelin receptor (GHS-R) agonist | Ghrelin receptor (GHS-R) agonist | Synthetic hexapeptide GH secretagogue | Selective ghrelin receptor (GHS-R) agonist |
| Route | Subcutaneous or intravenous | Intravenous in the published human work | Subcutaneous, intravenous or intranasal in studies | Subcutaneous injection |
| Half-life | ~1 hour | ~30–60 minutes | ~55 minutes | ~2 hours |
| Evidence grade | Limited | Limited | Limited | Preclinical |
| Oral stability | Not orally available | Not orally available | Poor oral bioavailability | Not orally available |
| Typical published cycle | Single-dose stimulation testing in the published work | Single or short repeated administration | Single-dose and short-course protocols | No established human protocol |
| Main studied use | Growth hormone stimulation testing | GH, ACTH and cortisol release; wound-healing research | Growth hormone release; cardiac research | Selective GH release without prolactin/cortisol rise |
References & evidence
Documents the GHRP-6 entry is written from. Each number matches an inline marker above.
- [1]Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal manFrieboes RM, Murck H, Maier P, et al. · Neuroendocrinology · 1995 · Peer-reviewed · PMID 7617137
- [2]Growth hormone-releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome studyFernández-Mayola M, Betancourt L, Molina-Kautzman A, et al. · International Wound Journal · 2018 · Peer-reviewed · PMID 29464859
How to track GHRP-6 doses
GHRP-6 is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so GHRP-6 is stored as a concentration rather than a guess. DoseRoutine converts that into mcg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mcg and the frequency (typical timing: bedtime). Cycled protocols get a start and end date so the history stays accurate when GHRP-6 comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 0.9 h, effects and timing shifts show up over days rather than instantly. Review GHRP-6 alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mcg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
References & Evidence
Sources on this page that document GHRP-6 dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is GHRP-6 studied for?
What is GHRP-6?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
GHRP-6, or Growth Hormone-Releasing Hexapeptide, is a synthetic peptide known for its ability to stimulate the release of growth hormone (GH) from the pituitary gland. It belongs to a class of compounds called growth hormone secretagogues. Unlike Growth Hormone-Releasing Hormone (GHRH), which primarily acts on GHRH receptors, GHRP-6 exerts its effects by binding to the ghrelin receptor. This action mimics the natural hormone ghrelin, often referred to as the 'hunger hormone,' leading to a pulsatile release of GH.
GHRP-6 was developed in the 1980s and has been studied for various potential applications due to its growth hormone-stimulating properties. It is typically administered via subcutaneous injection. While research has explored its therapeutic potential in conditions associated with GH deficiency, its use is more prevalent in research and athletic communities for its purported benefits related to muscle growth, fat loss, and recovery. It is important to note that GHRP-6 is not approved by regulatory bodies like the FDA for human use outside of specific research settings.
What does the research say about GHRP-6?
Tap a section to expand.
GHRP-6 functions as a synthetic ghrelin mimetic. Its primary mechanism of action involves binding to the growth hormone secretagogue receptor 1a (GHSR-1a), also known as the ghrelin receptor. These receptors are found in high concentrations in the anterior pituitary gland, which is responsible for producing and secreting growth hormone. By activating GHSR-1a, GHRP-6 triggers a signal cascade that directly stimulates somatotroph cells in the pituitary to release endogenous growth hormone.
This mechanism is distinct from GHRH, which acts on GHRH receptors to stimulate GH release. GHRP-6's action is synergistic with GHRH, meaning that when both are present, they can produce a greater GH release than either compound alone. Furthermore, GHRP-6's binding to GHSR-1a can also inhibit the action of somatostatin, a hormone that naturally suppresses GH release, thereby further promoting GH secretion. This dual action – direct stimulation and indirect inhibition of suppression – contributes to the robust GH release observed with GHRP-6 administration. (DrugBank)
Source for this section: Sources for How does GHRP-6 work?: Jumps to this entry in the sources and references list at the end of the page.
The potential benefits associated with GHRP-6 stem from its ability to elevate growth hormone levels. Elevated GH levels are implicated in several physiological processes relevant to muscle and recovery goals.
Potential benefits include:
* **Muscle Growth (Anabolism):** Growth hormone plays a crucial role in protein synthesis and nitrogen retention, which are fundamental processes for muscle tissue repair and growth. By increasing GH, GHRP-6 may support an anabolic environment conducive to muscle development. (PubChem)
* **Fat Loss (Lipolysis):** Growth hormone is also known to promote lipolysis, the breakdown of fat into free fatty acids, which can then be used for energy. This effect could contribute to a reduction in body fat mass. (PubChem)
* **Improved Recovery:** Enhanced growth hormone levels are associated with accelerated tissue repair and regeneration. This could lead to faster recovery from exercise-induced muscle damage and potentially improve healing of injuries. (PubChem)
* **Enhanced Bone Density:** Growth hormone contributes to bone metabolism and mineral density. While not a primary benefit, improved bone health could be a secondary effect. (DrugBank)
* **Anti-aging Effects:** Some proponents suggest that GHRP-6, by increasing GH, could contribute to general anti-aging effects, although this area requires more robust scientific investigation.
It is important to remember that these are potential benefits observed in research or anecdotal reports. The extent to which these benefits manifest in individual users can vary and depends on numerous factors including dosage, individual physiology, diet, and exercise regimen. The long-term safety and efficacy of GHRP-6 for these purposes in humans are not fully established.
Research into GHRP-6 has primarily been conducted in animal models and *in vitro* studies, with some limited human clinical trials focusing on its diagnostic potential for growth hormone deficiency. (NIH ODS)
* **Clinical Studies on GH Release:** Early human studies demonstrated GHRP-6's potent ability to stimulate GH release in both healthy individuals and those with GH deficiency, often showing a dose-dependent response. This confirmed its action as a growth hormone secretagogue. (PubChem)
* **Animal Models for Muscle and Fat:** Studies in animals have shown that GHRP-6 can increase lean body mass and reduce fat mass, supporting the proposed anabolic and lipolytic effects. However, direct extrapolation of these effects to humans always requires caution. (DrugBank)
* **Diagnostic Use:** GHRP-6 has been investigated for its potential as a diagnostic tool in assessing pituitary function and identifying GHRH-deficiency. (MedlinePlus)
Despite evidence of its physiological effects, the vast majority of claims regarding its benefits for muscle gain, fat loss, or recovery in healthy individuals are based on anecdotal evidence or extrapolation from studies not designed to assess these specific outcomes in humans. Due to its unapproved status, large-scale, placebo-controlled human trials investigating these specific performance-enhancing or body composition benefits are lacking. Therefore, while the mechanism of action is understood, robust clinical evidence for its widespread use in these applications is limited.
As GHRP-6 influences the endocrine system, it can lead to various side effects, primarily related to its growth hormone-stimulating and ghrelin-mimetic activities.
Commonly reported side effects include:
* **Increased Hunger:** This is a very common side effect due to GHRP-6's action on ghrelin receptors, which play a role in appetite regulation. Users often report a significant increase in appetite and food cravings.
* **Headaches:** Some individuals may experience headaches after administration.
* **Flushing:** A sensation of warmth or redness, particularly in the face and neck.
* **Dizziness:** Feelings of lightheadedness or unsteadiness.
* **Nausea:** Stomach upset or general discomfort.
* **Injection Site Reactions:** As an injectable peptide, localized pain, redness, itching, or swelling at the injection site is possible.
Less common but potential side effects related to sustained elevation of GH levels may include:
* **Water Retention/Bloating:** Increased GH can sometimes lead to fluid retention.
* **Carpal Tunnel Syndrome-like Symptoms:** Paresthesia (tingling/numbness) in the hands and wrists due to fluid retention and nerve compression.
* **Changes in Blood Sugar:** Growth hormone can affect insulin sensitivity and glucose metabolism, potentially leading to elevated blood sugar levels. (DrugBank)
* **Fatigue or Lethargy:** While some report increased energy, others may experience fatigue.
Long-term use of GHRP-6, particularly at supra-physiological doses, could theoretically lead to risks associated with chronic excess GH, such as acromegaly (abnormal growth of hands, feet, and face), although this is typically seen with pituitary tumors or exogenous recombinant human growth hormone use. The full extent of long-term side effects of GHRP-6 in otherwise healthy individuals is not well-established due to lack of comprehensive clinical trials. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Users of GHRP-6 should be aware of several warnings due to its unapproved status and potent physiological effects.
* **Unapproved for Human Use:** GHRP-6 is not approved by regulatory agencies like the FDA for human therapeutic use. Its quality, purity, and safety for human consumption cannot be guaranteed outside of controlled research settings.
* **Potential for Glucose Dysregulation:** GHRP-6's ability to elevate GH levels can affect insulin sensitivity and glucose metabolism. Individuals with pre-existing diabetes or insulin resistance should exercise extreme caution and monitor blood glucose closely. (DrugBank)
* **Purity and Contamination Concerns:** Due to its availability primarily through unregulated sources, there is a significant risk of receiving impure or contaminated products, which can pose severe health risks. Products may not contain the advertised amount of GHRP-6 or may contain other harmful substances.
* **Lack of Long-Term Safety Data:** Comprehensive human safety data, especially regarding long-term use, are scarce. The full spectrum of potential adverse effects and their severity over prolonged periods is unknown.
* **Risk of Acromegaly:** While typically associated with much higher GH levels or long-term exogenous GH use, theoretically, chronic use of GHRP-6 could contribute to conditions linked to excessive GH, such as acromegaly.
* **Increased Prolactin and Cortisol:** Some studies suggest that GHRP-6, particularly at higher doses, can transiently increase levels of prolactin and cortisol. Sustained elevation of these hormones can have various adverse effects. (DrugBank)
Individuals considering GHRP-6 should carefully weigh these warnings against its potential benefits. Self-administration of unapproved substances carries inherent risks. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Given its actions and the potential for adverse effects, GHRP-6 is contraindicated in several situations.
* **Pregnancy and Breastfeeding:** The effects of GHRP-6 on fetal development and infants are unknown. It should not be used by pregnant or breastfeeding women.
* **Cancer/Malignancy:** Growth hormone can stimulate cell growth and proliferation. Individuals with active cancer or a history of cancer should avoid GHRP-6, as it could potentially exacerbate tumor growth.
* **Diabetes Mellitus:** Individuals with diabetes, particularly uncontrolled diabetes, should avoid GHRP-6 due to its potential to affect glucose metabolism and insulin sensitivity, which could worsen glycemic control. (DrugBank)
* **High Blood Pressure (Hypertension):** Although direct effects are not fully established, some individuals may experience blood pressure fluctuations, and those with uncontrolled hypertension should use caution or avoid it.
* **Acute Critical Illness:** It is generally not recommended for use in acutely critically ill patients due to potential metabolic disturbances.
* **Pituitary Tumors:** Individuals with any pituitary gland disorders or tumors should avoid GHRP-6, as it directly stimulates the pituitary and could worsen existing conditions.
* **Allergy or Hypersensitivity:** Anyone with a known allergy or hypersensitivity to GHRP-6 or any of its components should not use it.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Mixing GHRP-6 with certain substances, particularly those that also impact hormone levels or metabolic processes, could lead to unpredictable or adverse outcomes.
* **Other Growth Hormone Secretagogues (GHSs):** While some protocols combine GHRP-6 with GHRH analogues (like CJC-1295), combining it with other non-GHRH GHSs or extremely high doses of GHRH analogues could potentially lead to excessively high GH levels, increasing the risk of adverse effects such as insulin resistance or acromegaly-like symptoms. Caution and careful monitoring are advised.
* **Insulin:** Due to GHRP-6's potential to alter glucose metabolism and insulin sensitivity, combining it with exogenous insulin or insulin-sensitizing medications could lead to unpredictable blood sugar fluctuations, including hypoglycemia or hyperglycemia. Close monitoring of blood glucose is critical if combined.
* **Corticosteroids:** Corticosteroids can suppress growth hormone secretion and activity. Concurrent use might diminish the intended effects of GHRP-6.
* **Somatostatin Analogues:** Somatostatin analogues are used to suppress growth hormone release. Combining them with GHRP-6 would counteract its primary mechanism of action and is generally illogical for the purpose of increasing GH.
* **High-Dose Thyroid Hormones:** While not a direct contraindication for *not mixing*, individuals with thyroid disorders should be carefully managed, as thyroid hormones interact with overall metabolism and endocrine function, which GHRP-6 also influences.
Always discuss all medications, supplements, and other compounds with a qualified healthcare professional before combining them with GHRP-6. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
GHRP-6 has a relatively short half-life of approximately 0.5 hours. To maximize its pulsatile effect on growth hormone release, it is often administered multiple times per day. A common administration strategy for GHRP-6 is to use it around specific times to leverage its effects on GH and appetite.
* **Before Bedtime:** Administration before bedtime is a common strategy as it may coincide with the body's natural nocturnal GH pulse and can help optimize GH release during sleep, a critical period for repair and regeneration. This timing may also help manage the increased hunger often associated with GHRP-6, as the user would be sleeping.
* **Post-Workout:** Some users administer GHRP-6 post-workout to potentially enhance recovery and muscle repair processes, capitalizing on the anabolic window.
* **Fasted State:** To achieve the most robust GH pulsatility, GHRP-6 is often recommended to be taken in a fasted state, typically at least 1-2 hours before or after consuming food, especially meals containing carbohydrates or fats. This is because ghrelin (which GHRP-6 mimics) and GH release can be blunted by high blood glucose or fatty acids. However, some anecdotal reports suggest this is less critical for the ghrelin receptor pathway than for GHRH pathways. The food rule is 'either'.
Dosage and specific timing should be user-directed and ideally set by a licensed clinician or researcher due to its unapproved status and individual variability in response.
Source for this section: Sources for When should you take GHRP-6?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with GHRP-6?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about GHRP-6
GHRP-6 is a research peptide. What follows is drawn from peer-reviewed literature indexed on PubMed, FDA label text where a label exists, and NIH reference records.
GHRP-6 is commonly discussed in the context of supporting weight-loss, recovery, and muscle. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For GHRP-6, it is typically administered by injection, it is typically taken in the evening, and its approximate half-life is 0.9 hours, which influences dosing frequency. Always follow the specific dose your clinician or the product label prescribes.
GHRP-6 carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.
GHRP-6 is a peptide, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because GHRP-6 is usually taken in the evening, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 0.9 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers GHRP-6 with no sign-up.
Combining a peptide like GHRP-6 with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Each peptide class carries its own profile against GHRP-6: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
A short plasma half-life of roughly 0.9 hours is why protocols often split GHRP-6 across the day rather than using a single dose. It is typically taken in the evening. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
Because GHRP-6 clears quickly (plasma half-life around 0.9 hours), a missed dose leaves a real gap in exposure rather than being buffered by what is still in your system. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like GHRP-6 the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at GHRP-6?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency(opens PubMed in a new tab)J Pediatr Endocrinol Metab · 1996 · PMID 8887178 · https://pubmed.ncbi.nlm.nih.gov/8887178/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 4345065(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/4345065
Verify at
Publisher search links for GHRP-6. These are places to check the information — they are not citations, so they are not numbered.
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on GHRP-6?
Plain-text summary, safe to quote verbatim:
GHRP-6, or Growth Hormone-Releasing Hexapeptide, is a synthetic peptide known for its ability to stimulate the release of growth hormone (GH) from the pituitary gland. It belongs to a class of compounds called growth hormone secretagogues. Research on GHRP-6 focuses on weight loss, tissue recovery, and muscle and strength.
Source: DoseRoutine — https://doseroutine.com/library/ghrp-6
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). GHRP-6 — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/ghrp-6
What compounds are similar to GHRP-6?
Others in the peptide category or studied for the same goals.
Which goals is GHRP-6 used for?
Other compounds studied for the same benefits as GHRP-6.
Continue exploring
See every compound DoseRoutine catalogs for these goals.